SYT1
Synaptotagmin-1
Also known as: P65, SVP65, SYT, SYT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21579
- Gene
- SYT1
- Ensembl
- ENSG00000067715
- Chromosome
- 12
- Canonical length
- 422 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the synaptotagmin protein family. The synaptotagmins are integral membrane proteins of synaptic vesicles that serve as calcium sensors in the process of vesicular trafficking and exocytosis. The encoded protein participates in triggering neurotransmitter release at the synapse in response to calcium binding. Mutations in this gene are associated with Baker-Gordon syndrome. [provided by RefSeq, Jan 2023]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>P21579|SYT1
1 MVSESHHEAL AAPPVTTVAT VLPSNATEPA SPGEGKEDAF SKLKEKFMNE LHKIPLPPWA
61 LIAIAIVAVL LVLTCCFCIC KKCLFKKKNK KKGKEKGGKN AINMKDVKDL GKTMKDQALK
121 DDDAETGLTD GEEKEEPKEE EKLGKLQYSL DYDFQNNQLL VGIIQAAELP ALDMGGTSDP
181 YVKVFLLPDK KKKFETKVHR KTLNPVFNEQ FTFKVPYSEL GGKTLVMAVY DFDRFSKHDI
241 IGEFKVPMNT VDFGHVTEEW RDLQSAEKEE QEKLGDICFS LRYVPTAGKL TVVILEAKNL
301 KKMDVGGLSD PYVKIHLMQN GKRLKKKKTT IKKNTLNPYY NESFSFEVPF EQIQKVQVVV
361 TVLDYDKIGK NDAIGKVFVG YNSTGAELRH WSDMLANPRR PIAQWHTLQV EEEVDAMLAV
421 KKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 280 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 280 nTPM
- retina: 187 nTPM
- cerebellum: 160 nTPM
- hippocampal formation: 109 nTPM
- amygdala: 82 nTPM
- hypothalamus: 79 nTPM
Single-cell type
- brain excitatory neurons: 3,471 nCPM
- brain inhibitory neurons: 3,227 nCPM
- cone photoreceptor cells: 3,037 nCPM
- retinal amacrine cells: 2,721 nCPM
- other brain neurons: 2,629 nCPM
- rod photoreceptor cells: 2,549 nCPM
Immune cell
- naive B-cell: 2.8 nTPM
- memory B-cell: 1.9 nTPM
- classical monocyte: 0.6 nTPM
- myeloid DC: 0.3 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 1,234 nTPM
- white matter: 697 nTPM
- basal ganglia: 612 nTPM
- hippocampal formation: 547 nTPM
- amygdala: 387 nTPM
- thalamus: 354 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SYT1.
Disease | AllUniProt
Conditions SYT1 is implicated in, by any mechanism.
- Baker-Gordon syndrome (BAGOS) MIM:618218
Disease | GeneticClinVar
22 pathogenic / likely-pathogenic of 115 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome
- SYT1-associated neurodevelopmental disorder
- Inborn genetic diseases
- Syndromic intellectual disability
- Neurodevelopmental disorder
ReferencesPubMed · IEDB
Publications for SYT1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
2008 · J Neuroimmunol · RCR 0.7 · 25 citations - Seasonal Coronavirus-Induced Immunological Imprinting and Previous Herpesvirus Infections in Patients With Long COVID.
2025 · J Med Virol · 3 citations
Reference: B cellIEDB
1 publication
- Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.
2017 · Int J Infect Dis · RCR 0.7 · 19 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.6
- gnomAD missense Z
- 2.84
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-dependent activation of synaptic vesicle fusion
- cell differentiation
- cellular response to calcium ion
- chemical synaptic transmission
- detection of calcium ion
- membraneless organelle assembly
- neurotransmitter secretion
- positive regulation of calcium ion-dependent exocytosis of neurotransmitter
- positive regulation of dendrite extension
- positive regulation of dopamine secretion
- positive regulation of synaptic transmission
- protein heterooligomerization
- regulation of calcium ion-dependent exocytosis
- regulation of exocytosis
- regulation of regulated secretory pathway
- regulation of synaptic transmission, glutamatergic
- regulation of synaptic vesicle exocytosis
- spontaneous neurotransmitter secretion
- vesicle docking
- vesicle fusion
- vesicle organization
- vesicle-mediated transport
- fast, calcium ion-dependent exocytosis of neurotransmitter
- synchronous neurotransmitter secretion
Molecular functions
- calcium ion binding
- calcium ion sensor activity
- calcium-dependent phospholipid binding
- calcium-dependent protein binding
- calmodulin binding
- clathrin binding
- identical protein binding
- lipid binding
- low-density lipoprotein particle receptor binding
- molecular condensate scaffold activity
- phosphatidylinositol-4,5-bisphosphate binding
- phosphatidylserine binding
- phospholipid binding
- protein heterodimerization activity
- SNARE binding
- syntaxin-1 binding
- syntaxin-3 binding
Cellular components
- axon
- chromaffin granule membrane
- clathrin-coated endocytic vesicle membrane
- clathrin-sculpted acetylcholine transport vesicle membrane
- clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane
- clathrin-sculpted glutamate transport vesicle membrane
- clathrin-sculpted monoamine transport vesicle membrane
- cytoplasm
- dense core granule
- excitatory synapse
- exocytic vesicle
- glutamatergic synapse
- Golgi apparatus
- hippocampal mossy fiber to CA3 synapse
- neuron projection
- neuron projection terminus
- plasma membrane
- postsynaptic cytosol
- postsynaptic density
- postsynaptic membrane
- presynaptic active zone
- presynaptic cytosol
- presynaptic membrane
- synaptic vesicle
- synaptic vesicle membrane
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SYT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYT1 as an antibody target. Whether an autoantibody or antibody against SYT1 could matter depends on whether native SYT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SYT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...